| Celgene Corporation | 91.24 / -0.30% |
| Date/Time | 07/17 / 18:46 |
| Chg. / Chg.(%) | -0.27 / -0.30% |
| Bid | 91.24 / 1 |
| Ask | 91.25 / 3 |
| Open | 91.53 |
| Previous Close | 91.51 |
| High | 91.65 |
| Low | 91.17 |
| Volume [USD] | 14,091,721.57 |
| Volume [Units] | 181,823 |
| Price fixings | 1441 |
| ISIN | US1510201049 |
| Security | CELG |
| Exchange | Cboe US |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 91.2600 |  |
1,796,546 |
| Cboe US | 91.24 | |
181,823 |
| IEX | 91.25 | |
66,553 |
| TradeGate | 81.620 | |
254 |
| Xetra | 81.28 | |
140 |
| Stuttgart | 81.350 | |
35 |
| London Inter.. | 91.49 | |
12 |
| Vienna Globa.. | 81.34 | |
0 |
| Frankfurt | 81.540 | |
0 |
| Berlin | 81.37 | |
0 |
| Düsseldorf | 81.28 | |
0 |
| Hamburg | 81.54 | |
0 |
| München | 81.79 | |
0 |
| Lang & Schwa.. | 81.240 | |
|
| gettex | 81.460 | |
|
| SIX Swiss Ex.. | 91.90 | ||
| SIX Swiss Ex.. | 89.40 | ||
| Mexico | 1,762.00 | 695 |
News
- Homology Medicines Appoints Alise Reicin, M.D., to the Board of Directors
07/15/2019 / 22:01 - GlobeNewswire - AZTherapies Strengthens Management Team, Adding Industry Veteran Jay Mohr as Chief Operating and Business Officer, Head of Commercial Development
07/10/2019 / 14:32 - GlobeNewswire - Priority Review Granted to BeiGene’s Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma
07/08/2019 / 02:00 - GlobeNewswire - BeiGene Granted Approval to Transition from the Biotech Chapter of the Hong Kong Stock Exchange to a General Listing
06/28/2019 / 15:25 - GlobeNewswire - Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer
06/26/2019 / 13:05 - GlobeNewswire
Real-time